coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Malling PCN, Tonbridge and Malling · Health Inequalities Profile

    PCN U05510 · NHS Kent and Medway Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    64,934

    Registered population

    58.6% aged 18–64

    19.0%

    Aged 65+

    ICB 19.9% · England 17.9%

    5.8%

    Ethnic minority (non-White)

    2.1% Asian · England 9.6%

    2.5%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~1,646

    Core20 residents (est.)

    Resident basis; registered basis ~1,649 · see page 3

    9,364

    Hypertension register

    +5.13% in 3 yrs · England +5.60%

    451

    SMI register

    43% of Tonbridge and Malling's

    1,091

    COPD register

    Reviews -6.96% in 3 yrs

    Forecast to 2030

    11,024

    Hypertension patients, 2030

    +1,660 on today

    70.5%

    QRISK ≥20% on statins, 2030

    +5.82pp over 3 yrs

    5.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.0%
    Heart failure annual reviews trail comparators.

    Annual reviews reached 57.0% versus 78.5% in England after a -6.0% three-year change (England +8.7%), which may reflect unverified recall gaps.

    8.6 pp
    MMR second dose lags first dose.

    At age 5, MMR dose 1 reaches 96.4% (above the 95.0% target), but dose 2 is 87.8%, an 8.6 pp same-cohort gap.

    77.2%
    Breast screening coverage exceeds national benchmark.

    Coverage is 77.2% against 69.9% in England and 71.6% in the ICB, after a +11.5% change over 2023 to 2024 (England +8.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Across 64,934 registered patients, children comprise 22.3% and older adults 19.0%

    Across 64,934 registered patients, Malling PCN serves higher proportions of children aged 0-17 (22.3%) than Tonbridge and Malling (21.4%), NHS Kent and Medway ICB (20.7%) and England (19.6%). Patients aged 65+ make up 19.0%, matching the borough (19.0%), trailing the ICB (19.9%) and exceeding England (17.9%). Resident Census estimates (reflecting local residents rather than registered patients) show 94.2% White ethnicity (borough 93.2%, ICB 88.6%, England 81.1%), a 5.8% ethnic minority share, and 0.4% Gypsy or Irish Traveller residents (borough 0.3%, ICB 0.3%, England 0.1%). Service planning must balance paediatric demand with older-adult care.

    Age profile

    0–1722.3%
    18–6458.6%
    65+19.0%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White94.2%
    Asian2.1%
    Mixed2.0%
    Black1.2%
    Other0.5%

    Older people · falls rows are Tonbridge and Malling local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Tonbridge and Malling LA)2,4582,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)77.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Tonbridge and Malling LA)1,1999819552024/25
    Falls deaths, all ages, per 100,000 (Tonbridge and Malling LA)15.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is low at 2.5% but heavily concentrated in one practice

    Malling PCN records a low Core20 cohort of 2.5%, against 2.4% in Tonbridge and Malling, 17.1% in NHS Kent and Medway ICB and 21.0% in England (average IMD decile 7.0). Deprivation is sharply concentrated: practice shares span 9.1 pp, led by Thornhills Medical Practice at 9.1% (estimated 1,326 patients), while Wateringbury records 1.4% and Snodland Medical Practice 0.0%. Practice estimates sum to 1,649, while resident Core20 estimates total 1,646 across different population bases. Focusing outreach at Thornhills Medical Practice rather than blanket deployment addresses the bulk of local Core20 need.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Thornhills9.1% · 1,326 patients
    Wateringbury1.4% · 158 patients
    West Malling0.8% · 165 patients
    Snodland Medical0.0% · 0 patients
    Phoenix Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    451

    SMI register

    0.70% recorded prevalence

    331

    Learning disability register

    0.51% recorded prevalence

    8

    Care homes, 376 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Tonbridge and Malling, Census 2021

    Severe mental illness recorded prevalence is 0.7% (451 patients; Tonbridge and Malling 0.7%, NHS Kent and Medway ICB 0.9%, England 1.0%) and learning disability is 0.5% (331 patients; borough 0.5%, ICB 0.6%, England 0.6%). Eight catchment care homes provide 376 beds, though resident registrations are unconfirmed. Lower recorded prevalence than England does not establish undiagnosed disease or under-detection, and catchment bed counts do not confirm patient registration.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks fell 4.2 pp over 2023 to 2025 to 76.8% (England +4.4 pp to 83.4%), while BMI checks fell 5.3 pp to 75.0% (England +5.1 pp to 82.1%). Declining checks risk unaddressed cardiometabolic illness.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,364

    Hypertension register

    +5.13%

    Register growth, 3 yrs

    Tonbridge and Malling +6.16% · England +5.60%

    +2.82pp

    BP control, under 80

    ≤140/90 · −1.12pp aged 80+

    +1,660

    More patients by 2030

    Forecast 11,024 (16.00%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 14.5% (9,364 patients), below Tonbridge and Malling (15.5%) and England (15.2%), giving an unadjusted benchmark scenario of +525 to +677 patients. Recent blood pressure checks reach 86.0% (England 90.0%), but treatment to target lags at 65.3% (England 70.3%). Control is 62.7% for patients aged under 80 (England 67.8%) and 76.3% for those aged 80 and over (England 81.2%), where control fell 1.4% over 2023 to 2025 (England +2.2%). Observation periods are unstated. Trailing national control may reflect treatment titration gaps, suggesting clinical reviews could help optimize regimens.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 56.8%, trailing Tonbridge and Malling (62.8%) and England (63.6%), alongside lower prescribing of 1,811 items per 1,000 adults aged 18+ in 2026 (England 4,100). Lower therapy reach may reflect primary prevention recall gaps.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202691,343£1.80£1.90£1.86£164,417
    Cardiovascular (all), 2025121,612£4.01£3.57£3.33£487,664

    In 2026, lipid-regulating drug prescribing reached 91,343 items at £1.80 per item, compared with £1.57 in Tonbridge and Malling and £1.86 in England, spending £5,481 less than at England's unit cost. Lower unit cost than England reflects favorable item spend, though prescribing reach requires review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +4.89%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.78%

    Asthma prevalence, PCN 3-yr % change

    COPD annual review completion is 62.0% (Tonbridge and Malling 66.2%, NHS Kent and Medway ICB 72.5%, England 76.4%), after reviews fell 7.0% over 2023 to 2025 (England +2.8%). COPD prevalence is 1.7% (1,091 patients). Asthma prevalence is 6.3% (3,797 patients), with review completion at 59.1% (England 65.7%), leaving an unreviewed scale indicator of 1,554 patients. Second-hand smoking status was recorded for 72.6% of asthma patients aged 6-19 (England 78.8%). Lower review completion may indicate recall gaps, risking unmanaged respiratory symptoms.

    Cancer register and children's immunisation

    Cancer prevalence is 4.4% (2,831 patients; England 3.8%). In childhood immunisations, age-5 MMR1 coverage reaches 96.4%, exceeding the 95.0% target. However, MMR2 coverage drops to 87.8% across the 197-child cohort—an 8.6 pp difference, falling 7.2 pp below target—and 4-in-1 booster coverage is 86.8%. At Phoenix Medical Practice, the MMR drop is 12.5 pp. The sharp second-dose drop leaves preschool children incompletely protected.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.1%

    England 91.0%

    6-in-1 complete primary course at 24 months90.9%

    England 92.2%

    MMR dose 1 at 24 months88.6%

    England 88.3%

    MMR dose 2 at age 587.8%

    England 82.8%

    4-in-1 pre-school booster at age 586.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, NHS Kent and Medway ICB recorded 55.6% of cancers with a known stage diagnosed at stage 1 or 2 (4,661 of 8,384 staged cases; England 55.3%), showing a distance of -19.4 pp to the 75.0% national ambition by 2028. Across all 13,189 registered cancers, staging coverage was 63.6% (England 67.0%), requiring 1,627 extra early-stage cases annually across the ICB to reach 75.0%. Early staging is not measured at PCN level, where Malling PCN registers 2,831 cancer patients (4.4% prevalence). Cervical screening reached 73.0% (England 66.8%), though 3-year change was -1.9% (England -1.0%). Active primary care recall is essential to prevent further screening erosion.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Maidstone and Tunbridge Wells NHS Trust met both cancer standards: 62-day referral to treatment was 87.4% (85.0% standard), ahead of Medway NHS Foundation Trust (81.6%), Dartford and Gravesham NHS Trust (63.6%), NHS Kent and Medway Integrated Care Board (75.9%) and England (71.2%). Its 28-day faster diagnosis reached 81.8% (75.0% standard; ICB 76.8%, England 79.3%). In diagnostics in Jul 2026, 6+ week waits were 0.5% for CT and 0.9% for MRI (England 9.9% and 21.4%). Local acute provider performance provides timely diagnostic access for urgent referrals.

    Pathways within standard (%)Maidstone and Tunbridge WellsMedwayDartford and GraveshamKent and Medway ICBEngland
    28-day faster diagnosis (75%)81.7877.7778.1476.7879.32
    31-day treatment (96%)98.3599.6297.4895.8492.50
    62-day referral to treatment (85%)87.4381.6463.5975.9371.16
    Diagnostic waits over 6 weeks (%)Maidstone and Tunbridge WellsMedwayDartford and GraveshamEngland
    MRI0.920.680.3621.40
    CT0.510.002.089.92
    Echocardiography2.5736.623.9028.48
    Colonoscopy19.801.880.4030.83
    Gastroscopy24.033.320.0029.02
    All 15 DM01 tests6.4214.208.3723.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In Jun 2026 (provisional), Tonbridge and Malling residents recorded 210,170 community service contacts, with 138,250 involving adults aged 65 and over, representing 65.8% of all contacts. These borough-level figures reflect community caseloads among older populations interfacing with primary care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans a 41.7 pp range despite high clinical QOF scores

    In 2025/26, clinical QOF achievement reached 97.3% at West Malling Group Practice and 100.0% at Phoenix Medical Practice (England 97.1%). Vaccination achievement spanned a 41.7 pp range, from 29.1% at Snodland Medical Practice to 70.8% at Phoenix Medical Practice (England 55.2%). Vaccination personalised care adjustments were 2.1% at Phoenix Medical Practice and 3.5% at West Malling Group Practice (England 4.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Wateringbury1181.466.0%74.6%83.5%
    Thornhills1089.132.4%76.5%69.9%
    Snodland Medical1110.059.2%82.4%65.1%
    West Malling1420.831.6%80.9%63.7%
    Phoenix Medical920.045.5%72.9%57.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTonbridge and MallingAssetPCNTonbridge and Malling
    Care homes (catchment)8 (376 beds)n/aSchools (catchment)53n/a
    Children's centres46Places of worship5175
    Libraries37Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)34
    Carers support groups (VCS)n/a2Primary schools (LA maintained)1528
    Primary academies1214Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension case-finding and treatment review

    Hypertension prevalence is 14.5% (9,364 patients) vs 15.2% in England and 15.5% in Tonbridge and Malling (+525 to +677 benchmark scenario); control is 65.3% (England 70.3%). For discussion: practices could pair uncoded raised BP searches with pharmacist-led titration and lipid reviews (QRISK >= 20% therapy is 56.8%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured asthma and respiratory review recall

    Asthma review completion is 59.1% vs England's 65.7% (leaving a scale indicator of 1,554 of 3,797 patients unreviewed), while COPD reviews fell 7.0% to 62.0%. For discussion: the PCN could run a standardised respiratory recall using flexible after-school or remote slots and check inhaler prescribing at review. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Combined SMI physical health check recall

    On the 451-patient SMI register, annual BP checks fell 4.2 pp over 2023 to 2025 to 76.8% (England 83.4%), and BMI checks fell 5.3 pp to 75.0% (England 82.1%). For discussion: practices could introduce a single combined-check appointment, audit partial component recording, and assign named outreach leads for non-attenders. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Inclusion health community engagement (p2)Gypsy or Irish TravellerNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension medication titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Hypertension case-finding and treatment review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured asthma and respiratory review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD patients with a review in the last 12 monthsCore20PLUS5 respiratoryPCN
    Option 3 · Combined SMI physical health check recall (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15